- call +1-201-465-4211
- email sales@mrinsights.biz
Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered.
Scope of the Report:
Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body.
Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
The factors driving this market include increasing hospitalization rate and rise in demand for faster, safer and effective administration of drugs. The introduction of single dosage nervous system disorders, oncology and diabetes would provide opportunities for growth of this market.
The worldwide market for Large Volume Parenteral (LVP) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Large Volume Parenteral (LVP) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Southwest Pharmaceutical
Cook Pharmica
Beximco Pharma
Baxter Healthcare Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fluid Balance Injections
Therapeutic Injections
Nutritious Injections
Market Segment by Applications, can be divided into
Hospitals
Medical Centers
Others
There are 15 Chapters to deeply display the global Large Volume Parenteral (LVP) market.
Chapter 1, to describe Large Volume Parenteral (LVP) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Large Volume Parenteral (LVP), with sales, revenue, and price of Large Volume Parenteral (LVP), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Large Volume Parenteral (LVP), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Large Volume Parenteral (LVP) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Large Volume Parenteral (LVP) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Large Volume Parenteral (LVP) Introduction
1.2 Market Analysis by Type
1.2.1 Fluid Balance Injections
1.2.2 Therapeutic Injections
1.2.3 Nutritious Injections
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Medical Centers
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Ostuka Pharmaceutical
2.1.1 Business Overview
2.1.2 Large Volume Parenteral (LVP) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva Pharmaceutical Industries
2.2.1 Business Overview
2.2.2 Large Volume Parenteral (LVP) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Kelun Pharma
2.3.1 Business Overview
2.3.2 Large Volume Parenteral (LVP) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cook Pharmica
2.4.1 Business Overview
2.4.2 Large Volume Parenteral (LVP) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Patheon
2.5.1 Business Overview
2.5.2 Large Volume Parenteral (LVP) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Patheon Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 BAG Healthcare
2.6.1 Business Overview
2.6.2 Large Volume Parenteral (LVP) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Southwest Pharmaceutical
2.7.1 Business Overview
2.7.2 Large Volume Parenteral (LVP) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Southwest Pharmaceutical Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cook Pharmica
2.8.1 Business Overview
2.8.2 Large Volume Parenteral (LVP) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Beximco Pharma
2.9.1 Business Overview
2.9.2 Large Volume Parenteral (LVP) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Baxter Healthcare Corporation
2.10.1 Business Overview
2.10.2 Large Volume Parenteral (LVP) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Baxter Healthcare Corporation Large Volume Parenteral (LVP) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Large Volume Parenteral (LVP) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Large Volume Parenteral (LVP) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Large Volume Parenteral (LVP) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Large Volume Parenteral (LVP) Manufacturer Market Share in 2017
3.3.2 Top 6 Large Volume Parenteral (LVP) Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Large Volume Parenteral (LVP) Market Analysis by Regions
4.1 Global Large Volume Parenteral (LVP) Sales, Revenue and Market Share by Regions
4.1.1 Global Large Volume Parenteral (LVP) Sales and Market Share by Regions (2013-2018)
4.1.2 Global Large Volume Parenteral (LVP) Revenue and Market Share by Regions (2013-2018)
4.2 North America Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
4.3 Europe Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
4.5 South America Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
5 North America Large Volume Parenteral (LVP) by Countries
5.1 North America Large Volume Parenteral (LVP) Sales, Revenue and Market Share by Countries
5.1.1 North America Large Volume Parenteral (LVP) Sales and Market Share by Countries (2013-2018)
5.1.2 North America Large Volume Parenteral (LVP) Revenue and Market Share by Countries (2013-2018)
5.2 United States Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
5.3 Canada Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
5.4 Mexico Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
6 Europe Large Volume Parenteral (LVP) by Countries
6.1 Europe Large Volume Parenteral (LVP) Sales, Revenue and Market Share by Countries
6.1.1 Europe Large Volume Parenteral (LVP) Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Large Volume Parenteral (LVP) Revenue and Market Share by Countries (2013-2018)
6.2 Germany Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
6.3 UK Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
6.4 France Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
6.5 Russia Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
6.6 Italy Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
7 Asia-Pacific Large Volume Parenteral (LVP) by Countries
7.1 Asia-Pacific Large Volume Parenteral (LVP) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Large Volume Parenteral (LVP) Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Large Volume Parenteral (LVP) Revenue and Market Share by Countries (2013-2018)
7.2 China Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
7.3 Japan Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
7.4 Korea Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
7.5 India Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
8 South America Large Volume Parenteral (LVP) by Countries
8.1 South America Large Volume Parenteral (LVP) Sales, Revenue and Market Share by Countries
8.1.1 South America Large Volume Parenteral (LVP) Sales and Market Share by Countries (2013-2018)
8.1.2 South America Large Volume Parenteral (LVP) Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
8.3 Argentina Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
8.4 Colombia Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
9 Middle East and Africa Large Volume Parenteral (LVP) by Countries
9.1 Middle East and Africa Large Volume Parenteral (LVP) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Large Volume Parenteral (LVP) Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
9.3 UAE Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
9.4 Egypt Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
9.5 Nigeria Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
9.6 South Africa Large Volume Parenteral (LVP) Sales and Growth Rate (2013-2018)
10 Global Large Volume Parenteral (LVP) Market Segment by Type
10.1 Global Large Volume Parenteral (LVP) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Large Volume Parenteral (LVP) Sales and Market Share by Type (2013-2018)
10.1.2 Global Large Volume Parenteral (LVP) Revenue and Market Share by Type (2013-2018)
10.2 Fluid Balance Injections Sales Growth and Price
10.2.1 Global Fluid Balance Injections Sales Growth (2013-2018)
10.2.2 Global Fluid Balance Injections Price (2013-2018)
10.3 Therapeutic Injections Sales Growth and Price
10.3.1 Global Therapeutic Injections Sales Growth (2013-2018)
10.3.2 Global Therapeutic Injections Price (2013-2018)
10.4 Nutritious Injections Sales Growth and Price
10.4.1 Global Nutritious Injections Sales Growth (2013-2018)
10.4.2 Global Nutritious Injections Price (2013-2018)
11 Global Large Volume Parenteral (LVP) Market Segment by Application
11.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Medical Centers Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Large Volume Parenteral (LVP) Market Forecast (2018-2023)
12.1 Global Large Volume Parenteral (LVP) Sales, Revenue and Growth Rate (2018-2023)
12.2 Large Volume Parenteral (LVP) Market Forecast by Regions (2018-2023)
12.2.1 North America Large Volume Parenteral (LVP) Market Forecast (2018-2023)
12.2.2 Europe Large Volume Parenteral (LVP) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Large Volume Parenteral (LVP) Market Forecast (2018-2023)
12.2.4 South America Large Volume Parenteral (LVP) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Large Volume Parenteral (LVP) Market Forecast (2018-2023)
12.3 Large Volume Parenteral (LVP) Market Forecast by Type (2018-2023)
12.3.1 Global Large Volume Parenteral (LVP) Sales Forecast by Type (2018-2023)
12.3.2 Global Large Volume Parenteral (LVP) Market Share Forecast by Type (2018-2023)
12.4 Large Volume Parenteral (LVP) Market Forecast by Application (2018-2023)
12.4.1 Global Large Volume Parenteral (LVP) Sales Forecast by Application (2018-2023)
12.4.2 Global Large Volume Parenteral (LVP) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Large Volume Parenteral (LVP) Picture
Table Product Specifications of Large Volume Parenteral (LVP)
Figure Global Sales Market Share of Large Volume Parenteral (LVP)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
